Squarepoint
IDXX icon

Squarepoint’s Idexx Laboratories IDXX Stock Holding History

Squarepoint’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-3,400
Closed -$2.17M – 4541
2025
Q3 		$2.17M Buy
3,400
+2,100
+162% +$1.27M ﹤0.01% 2027
2025
Q2 		$697K Buy
+1,300
New +$622K ﹤0.01% 2980
2024
Q2 		– Sell
-5,100
Closed -$2.75M – 4335
2024
Q1 		$2.75M Buy
+5,100
New +$2.79M ﹤0.01% 1889

Other funds holding IDXX

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.6B AUM 22.09% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
AustralianSuper
AustralianSuper Melbourne, Australia $24.4B AUM 44.82% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Squarepoint's IDXX Position: Q3 2026 in Review

Squarepoint reduced its Idexx Laboratories (IDXX) stake by 31% in Q3 2026, selling an estimated $53.5M and leaving 217,528 shares worth $114M. The position accounts for 0.13% of the portfolio, ranked #139.

Squarepoint first reported a position in IDXX in Q1 2015 and has held it in 36 quarters since. The position peaked at $166M in Q2 2026. 804 funds tracked by Wall St. Rank hold IDXX as of Q3 2026.

  • Squarepoint held 217,528 shares of Idexx Laboratories worth $114M as of Q3 2026.
  • Squarepoint sold 97,636 Idexx Laboratories shares in Q3 2026, an estimated $53.5M.
  • Idexx Laboratories made up 0.13% of Squarepoint's portfolio in Q3 2026, its #139 holding.
  • Squarepoint first reported a position in Idexx Laboratories in Q1 2015 and has held it in 36 quarters since.
  • Squarepoint's Idexx Laboratories position peaked at $166M in Q2 2026.
  • 804 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2026.

Based on Squarepoint's 13F filing for Q3 2026, filed 9 Nov 2026.